The SDH Mutation Database: an Online Resource for Succinate Dehydrogenase Sequence Variants Involved in Pheochromocytoma, Paraganglioma and Mitochondrial Complex II Deficiency

Overview

Journal BMC Med Genet

Publisher Biomed Central

Specialty Genetics

Date 2005 Nov 18

PMID 16288654

Citations 67

Authors

Jean-Pierre Bayley

Peter Devilee

Peter E M Taschner

Affiliations

Soon will be listed here.

Abstract

Background: The SDHA, SDHB, SDHC and SDHD genes encode the subunits of succinate dehydrogenase (succinate: ubiquinone oxidoreductase), a component of both the Krebs cycle and the mitochondrial respiratory chain. SDHA, a flavoprotein and SDHB, an iron-sulfur protein together constitute the catalytic domain, while SDHC and SDHD encode membrane anchors that allow the complex to participate in the respiratory chain as complex II. Germline mutations of SDHD and SDHB are a major cause of the hereditary forms of the tumors paraganglioma and pheochromocytoma. The largest subunit, SDHA, is mutated in patients with Leigh syndrome and late-onset optic atrophy, but has not as yet been identified as a factor in hereditary cancer.

Description: The SDH mutation database is based on the recently described Leiden Open (source) Variation Database (LOVD) system. The variants currently described in the database were extracted from the published literature and in some cases annotated to conform to current mutation nomenclature. Researchers can also directly submit new sequence variants online. Since the identification of SDHD, SDHC, and SDHB as classic tumor suppressor genes in 2000 and 2001, studies from research groups around the world have identified a total of 120 variants. Here we introduce all reported paraganglioma and pheochromocytoma related sequence variations in these genes, in addition to all reported mutations of SDHA. The database is now accessible online.

Conclusion: The SDH mutation database offers a valuable tool and resource for clinicians involved in the treatment of patients with paraganglioma-pheochromocytoma, clinical geneticists needing an overview of current knowledge, and geneticists and other researchers needing a solid foundation for further exploration of both these tumor syndromes and SDHA-related phenotypes.

Citing Articles

A Novel Human SDHA-Knockout Cell Line Model for the Functional Analysis of Clinically Relevant SDHA Variants.

Kent J, Klug L, Heinrich M Clin Cancer Res. 2024; 30(23):5399-5412.

PMID: 39321216 PMC: 11611653. DOI: 10.1158/1078-0432.CCR-24-1601.

Pheochromocytoma/Paraganglioma Syndrome Type 1 Presenting with Atypical Symptoms and a Novel Pathogenic Variant in the Gene: A Case Report.

Zohrehvand E, Injinari N, Kiani Feyzabadi M, Aghili K, Ghaemi F, Azizi R Arch Iran Med. 2024; 27(8):447-451.

PMID: 39306716 PMC: 11416696. DOI: 10.34172/aim.28810.

Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome.

Cicchetti R, Basconi M, Litterio G, Mascitti M, Tamborino F, Orsini A Int J Mol Sci. 2024; 25(16).

PMID: 39201746 PMC: 11355026. DOI: 10.3390/ijms25169060.

Unraveling the functional consequences of a novel germline missense mutation (R38C) in the yeast model of succinate dehydrogenase subunit B: insights into neurodegenerative disorders.

Zheng J, Liu S, Wang D, Li L, Sarsaiya S, Zhou H Front Mol Neurosci. 2023; 16:1246842.

PMID: 37840772 PMC: 10568460. DOI: 10.3389/fnmol.2023.1246842.

An evolving view of complex II-noncanonical complexes, megacomplexes, respiration, signaling, and beyond.

Iverson T, Singh P, Cecchini G J Biol Chem. 2023; 299(6):104761.

PMID: 37119852 PMC: 10238741. DOI: 10.1016/j.jbc.2023.104761.

References

Favier J, Briere J, Strompf L, Amar L, Filali M, Jeunemaitre X . Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm Res. 2005; 63(4):171-9. DOI: 10.1159/000084685. View

Heutink P, van Schothorst E, van der Mey A, Bardoel A, Breedveld G, Pertijs J . Further localization of the gene for hereditary paragangliomas and evidence for linkage in unrelated families. Eur J Hum Genet. 1994; 2(3):148-58. DOI: 10.1159/000472358. View

Tomitsuka E, Goto Y, Taniwaki M, Kita K . Direct evidence for expression of type II flavoprotein subunit in human complex II (succinate-ubiquinone reductase). Biochem Biophys Res Commun. 2003; 311(3):774-9. DOI: 10.1016/j.bbrc.2003.10.065. View

Heutink P, van der Mey A, Sandkuijl L, van Gils A, Bardoel A, Breedveld G . A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet. 1992; 1(1):7-10. DOI: 10.1093/hmg/1.1.7. View

Baysal B, Willett-Brozick J, Lawrence E, Drovdlic C, Savul S, McLeod D . Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet. 2002; 39(3):178-83. PMC: 1735061. DOI: 10.1136/jmg.39.3.178. View

Neumann H, Pawlu C, Peczkowska M, Bausch B, McWhinney S, Muresan M . Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004; 292(8):943-51. DOI: 10.1001/jama.292.8.943. View

Lemire B, Oyedotun K . The Saccharomyces cerevisiae mitochondrial succinate:ubiquinone oxidoreductase. Biochim Biophys Acta. 2002; 1553(1-2):102-16. DOI: 10.1016/s0005-2728(01)00229-8. View

Gimenez-Roqueplo A, Favier J, Rustin P, Rieubland C, Kerlan V, Plouin P . Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab. 2002; 87(10):4771-4. DOI: 10.1210/jc.2002-020525. View

Braun S, Riemann K, Kupka S, Leistenschneider P, Sotlar K, Schmid H . Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas. Anticancer Res. 2005; 25(4):2809-14. View

10.

Maier-Woelfle M, Brandle M, Komminoth P, Saremaslani P, Schmid S, Locher T . A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomas. J Clin Endocrinol Metab. 2004; 89(1):362-7. DOI: 10.1210/jc.2003-031236. View

11.

Hensen E, Jordanova E, van Minderhout I, Hogendoorn P, Taschner P, van der Mey A . Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene. 2004; 23(23):4076-83. DOI: 10.1038/sj.onc.1207591. View

12.

Baysal B, Ferrell R, Willett-Brozick J, Lawrence E, Myssiorek D, Bosch A . Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000; 287(5454):848-51. DOI: 10.1126/science.287.5454.848. View

13.

Niemann S, Muller U . Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet. 2000; 26(3):268-70. DOI: 10.1038/81551. View

14.

Fokkema I, den Dunnen J, Taschner P . LOVD: easy creation of a locus-specific sequence variation database using an "LSDB-in-a-box" approach. Hum Mutat. 2005; 26(2):63-8. DOI: 10.1002/humu.20201. View

15.

Astuti D, Hart-Holden N, Latif F, Lalloo F, Black G, Lim C . Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin Endocrinol (Oxf). 2004; 59(6):728-33. DOI: 10.1046/j.1365-2265.2003.01914.x. View

16.

Cascon A, Ruiz-Llorente S, Cebrian A, Telleria D, Rivero J, Diez J . Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma. Eur J Hum Genet. 2002; 10(8):457-61. DOI: 10.1038/sj.ejhg.5200829. View

17.

Margetts C, Astuti D, Gentle D, Cooper W, Cascon A, Catchpoole D . Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocr Relat Cancer. 2005; 12(1):161-72. DOI: 10.1677/erc.1.00865. View

18.

den Dunnen J, Antonarakis S . Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 1999; 15(1):7-12. DOI: 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N. View

19.

Hirawake H, Taniwaki M, Tamura A, Amino H, Tomitsuka E, Kita K . Characterization of the human SDHD gene encoding the small subunit of cytochrome b (cybS) in mitochondrial succinate-ubiquinone oxidoreductase. Biochim Biophys Acta. 1999; 1412(3):295-300. DOI: 10.1016/s0005-2728(99)00071-7. View

20.

Simi L, Sestini R, Ferruzzi P, Gagliano M, Gensini F, Mascalchi M . Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. J Med Genet. 2005; 42(8):e52. PMC: 1736123. DOI: 10.1136/jmg.2004.030353. View